Sanolium AB announces leadership transition
Stockholm, 19 April 2021 – Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, today announces that its Board of Directors has named Lars Andåker as interim Chief Executive Officer, effective immediately.Lars Andåker succeeds Peter Gille, who has left the Company. Lars Andåker is a board member and has been with the business since 2012. He previously held the role of interim Chief Executive Officer for Cambio in 2014-2015. Lars Andåker is an experienced executive in the healthcare sector with prior roles including CEO of the Swedish Medical Association,